Patents and access to Lymphoma medicines

Non-Hodgkin’s Lymphoma, associated in particular with the People Living with HIV, is steadily increasing. The success of ARV treatments has the negative impact of a compromised immune system that is more susceptible to cancers such as non-Hodgkin’s Lymphoma, cervical cancer associated with the human papilloma virus and Kaposi Sarcoma. Preliminary results from a study focusing […]